The enteropathogenic Escherichia coli-secreted protein EspZ inhibits host cell apoptosis

Infection and Immunity

Volumn 80, Issue 11, 2012, Pages 3850-3857

  Roxas, Jennifer Lising ^a   Wilbur, John Scott ^a   Zhang, Xiangfeng ^a   Martinez, Giovanna ^a   Vedantam, Gayatri ^a,b,c   Viswanathan, V K ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 7; CASPASE 9; CYCLOHEXIMIDE; CYTOCHROME C; ESCHERICHIA COLI PROTEIN; ESCHERICHIA COLI PROTEIN ESPZ; FOCAL ADHESION KINASE; STAUROSPORINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BACTERIAL STRAIN; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; CYTOSOL; ENTEROPATHOGENIC ESCHERICHIA COLI; ENZYME ACTIVATION; GENETIC TRANSFECTION; HOST CELL; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; MITOCHONDRION; PRIORITY JOURNAL;

APOPTOSIS; CELLS, CULTURED; ENTEROPATHOGENIC ESCHERICHIA COLI; EPITHELIAL CELLS; ESCHERICHIA COLI PROTEINS; HUMANS; INTESTINES; SIGNAL TRANSDUCTION;

EID: 84867588972     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00335-12     Document Type: Article

References (37)

1. Abul-Milh M, Wu Y, Lau B, Lingwood CA, Barnett Foster D. 2001. Induction of epithelial cell death including apoptosis by enteropathogenic Escherichia coli expressing bundle-forming pili. Infect. Immun. 69:7356-7364.
2. Baruch K, et al. 2011. Metalloprotease type III effectors that specifically cleave JNK and NF-kappaB. EMBO J. 30:221-231.
3. Chae HJ, et al. 2000. Molecular mechanism of staurosporine-induced apoptosis in osteoblasts. Pharmacol. Res. 42:373-381.
4. Chua BT, Guo K, Li P. 2000. Direct cleavage by the calcium-activated protease calpain can lead to inactivation of caspases. J. Biol. Chem. 275:5131-5135.
5. Crane JK, Majumdar S, Pickhardt DF III. 1999. Host cell death due to enteropathogenic Escherichia coli has features of apoptosis. Infect. Immun. 67:2575-2584.
6. Crane JK, McNamara BP, Donnenberg MS. 2001. Role of EspF in host cell death induced by enteropathogenic Escherichia coli. Cell. Microbiol.3:197-211.
7. Crane JK, Oh JS. 1997. Activation of host cell protein kinase C by enteropathogenic Escherichia coli. Infect. Immun. 65:3277-3285.
8. Dean P, Kenny B. 2009. The effector repertoire of enteropathogenic E.coli: ganging up on the host cell. Curr. Opin. Microbiol. 12:101-109.
9. Deng W, et al. 2004. Dissecting virulence: systematic and functional analyses of a pathogenicity island. Proc. Natl. Acad. Sci. U. S. A. 101:3597-3602.
10. Faherty CS, Maurelli AT. 2008. Staying alive: bacterial inhibition of apoptosis during infection. Trends Microbiol. 16:173-180.
11. Gilmour MW, et al. 2006. Use of the espZ gene encoded in the locus of enterocyte effacement for molecular typing of Shiga toxin-producing Escherichia coli. J. Clin. Microbiol. 44:449-458.
12. Heczko U, Carthy CM, O'Brien BA, Finlay BB. 2001. Decreased apoptosis in the ileum and ileal Peyer's patches: a feature after infection with rabbit enteropathogenic Escherichia coli O103. Infect. Immun. 69:4580-4589.
13. Inada H, et al. 2001. Keratin attenuates tumor necrosis factor-induced cytotoxicity through association with TRADD. J. Cell Biol. 155:415-426.
14. Kabir J, Lobo M, Zachary I. 2002. Staurosporine induces endothelial cell apoptosis via focal adhesion kinase dephosphorylation and focal adhesion disassembly independent of focal adhesion kinase proteolysis. Biochem. J.367:145-155.
15. Kanack KJ, Crawford JA, Tatsuno I, Karmali MA, Kaper JB. 2005.SepZ/EspZ is secreted and translocated into HeLa cells by the enteropathogenic Escherichia coli type III secretion system. Infect. Immun. 73:4327-4337.
16. Kenny B, Jepson M. 2000. Targeting of an enteropathogenic Escherichia coli (EPEC) effector protein to host mitochondria. Cell. Microbiol. 2:579-590.
17. Knutton S. 1995. Electron microscopical methods in adhesion. Methods Enzymol. 253:145-158.
18. Kosek M, Bern C, Guerrant RL. 2003. The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000. Bull.World Health Organ. 81:197-204.
19. Lin Y, Devin A, Rodriguez Y, Liu ZG. 1999. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. GenesDev. 13:2514 -2526.
20. Malish HR, et al. 2003. Potential role of the EPEC translocated intimin receptor (Tir) in host apoptotic events. Apoptosis 8:179 -190.
21. Malladi V, Puthenedam M, Williams PH, Balakrishnan A. 2004. Enteropathogenic Escherichia coli outer membrane proteins induce iNOS by activation of NF-kappaB and MAP kinases. Inflammation 28:345-353.
22. Malladi V, Shankar B, Williams PH, Balakrishnan A. 2004. Enteropathogenic Escherichia coli outer membrane proteins induce changes in cadherin junctions of Caco-2 cells through activation of PKCalpha. MicrobesInfect. 6:38 -50.
23. McKenzie GJ, Craig NL. 2006. Fast, easy and efficient: site-specific insertion of transgenes into enterobacterial chromosomes using Tn7 without need for selection of the insertion event. BMC Microbiol. 6:39. doi:10.1186/1471-2180-6-39.
24. Melo AR, et al. 2005. Expression of the virulence factor, BfpA, by enteropathogenic Escherichia coli is essential for apoptosis signalling but not for NF-kappaB activation in host cells. Scand. J. Immunol. 61:511-519.
25. Mills E, Baruch K, Charpentier X, Kobi S, Rosenshine I. 2008. Real-time analysis of effector translocation by the type III secretion system of enteropathogenic Escherichia coli. Cell Host Microbe 3:104 -113.
26. Nagai T, Abe A, Sasakawa C. 2005. Targeting of enteropathogenic Escherichia coli EspF to host mitochondria is essential for the bacterial pathogenesis: critical role of the 16th leucine residue in EspF. J. Biol. Chem.280:2998 -3011.
27. Nataro JP, Kaper JB. 1998. Diarrheagenic Escherichia coli. Clin. Microbiol.Rev. 11:142-201.
28. Nougayrede JP, Donnenberg MS. 2004. Enteropathogenic Escherichia coli EspF is targeted to mitochondria and is required to initiate the mitochondrial death pathway. Cell. Microbiol. 6:1097-1111.
29. Nougayrede JP, Foster GH, Donnenberg MS. 2007. Enteropathogenic Escherichia coli effector EspF interacts with host protein Abcf2. Cell. Microbiol.9:680-693.
30. Peterson MD, Mooseker MS. 1992. Characterization of the enterocytelike brush border cytoskeleton of the C2BBe clones of the human intestinal cell line, Caco-2. J. Cell Sci. 102:581-600.
31. Roxas JL, Koutsouris A, Viswanathan VK. 2007. Enteropathogenic Escherichia coli-induced epidermal growth factor receptor activation contributesto physiological alterations in intestinal epithelial cells. Infect. Immun.75:2316 -2324.
32. Sason H, et al. 2009. Enteropathogenic Escherichia coli subverts phosphatidylinositol4,5-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate upon epithelial cell infection. Mol. Biol. Cell 20:544 -555.
33. Shames SR, Croxen MA, Deng W, Finlay BB. 2011. The type III systemsecreted effector EspZ localizes to host mitochondria and interacts with the translocase of inner mitochondrial membrane (TIM) 17b. Infect. Immun.79:4784-4790.
34. Shames SR, et al. 2010. The pathogenic E. coli type III effector EspZ interacts with host CD98 and facilitates host cell prosurvival signalling. Cell. Microbiol. 12:1322-1339.
35. Tegtmeyer N, Backert S. 2009. Bacterial type III effectors inhibit cell lifting by targeting integrin-linked kinase. Cell Host Microbe 5:514 -516.
36. Vossenkamper A, Macdonald TT, Marches O. 2011. Always one step ahead: how pathogenic bacteria use the type III secretion system to manipulate the intestinal mucosal immune system. J. Inflamm. 8:11. doi:10.1186/1476-9255-8-11.
37. Wong AR, et al. 2011. Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements. Mol. Microbiol. 80:1420-1438.